The Role of Neutrophil to Lymphocyte Ratio in Predicting Clinical Outcomes in Chronic Obstructive Pulmonary Disease Patients: A Single-Center Cohort Study

Document Type : Original Article

Authors

1 Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Lung Diseases Research Center, Mashhad University of Medical Science, Mashhad, Iran.

3 Student Research Committee, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

Abstract

Introduction: The primary objective of the study was to scrutinize the neutrophil to lymphocyte ratio (NLR) in patients afflicted with chronic obstructive pulmonary disease (COPD).
Methods: This study, conducted at Mashhad University of Medical Sciences in Iran between 2021-2022, aimed to analyze the NLR. Data were collected from medical records, laboratory reports, and personal interviews, focusing on demographic data, clinical histories, and various laboratory and clinical parameters. The severity of COPD was assessed using several clinical scales and spirometry measurements. Statistical analysis was performed using SPSS and R software.
Results: In this study, a cohort of 49 patients with COPD was analyzed, with a majority being male (59%) and having an average age of 62.3 years. The mean NLR was 2.1. The correlation analysis showed a moderate negative correlation between Ejection Fraction and NLR (rho = -0.30, p = 0.03), and a weak positive correlation between Erythrocyte Sedimentation Rate and NLR (rho = 0.28, p = 0.04). Comparative analysis of NLR with COPD clinical scales showed a significant rise in NLR from category 0 to 2 in AECOPD cases (p=0.04). Concurrent ROC analysis indicates a diagnostic power of 0.68, establishing an NLR cutoff value of 1.67, with a sensitivity of 0.67 and a specificity of 0.71.
Conclusions: NLR may serve as a marker for mild to moderate exacerbations in COPD patients (categories 1 and 2); however, its predictive value for severe exacerbations (category 3) remains unclear. Further research is needed to explore the underlying mechanisms and its utility across the full spectrum of exacerbation severity.

Keywords

References

  1. Yang X, Zhang T, Zhang Y, Chen H, Sang S. Global burden of COPD attributable to ambient PM2. 5 in 204 countries and territories, 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Science of the Total Environment. 2021 Nov 20;796:148819.
  2.  Shaw JG, Vaughan A, Dent AG, O’Hare PE, Goh F, Bowman RV, et al. Biomarkers of progression of chronic obstructive pulmonary disease (COPD). Journal of thoracic disease. 2014 Nov;6(11):1532..
  3.  Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021 Jan 1;122(7):474-88.
  4. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Journal of the National Cancer Institute. 2014 Jun 1;106(6):dju124.
  5. Yaghoubi MA, Mehrad-Majd H, Moradi A, Vakilzadeh MM, Khorasani ZM, Ghavi M, et al. The Prognostic Role of Corticosteroid Administration in Hospitalized Patients with Severe COVID-19: A Cross-sectional Study. Recent Advances in Inflammation & Allergy Drug Discovery. 2023 Sep 1;17(2):152-7.
  6. Forouzanfar F, Vakilzadeh MM, Mehri A, Pourbagher-Shahri AM, Ganjali S, Abbasifard M, et al. Anti-arthritic and Antioxidant Effects of Trehalose in an Experimental Model of Arthritis. Recent Advances in Inflammation & Allergy Drug Discovery. 2023 Sep 1;17(2):145-51.
  7. Shao S, Zhang Z, Feng L, Liang L, Tong Z. Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD: An 8-Year Retrospective Study in Beijing. International Journal of Chronic Obstructive Pulmonary Disease. 2023 Dec 31:1783-802.
  8. Zinellu A, Zinellu E, Pau MC, Carru C, Pirina P, Fois AG, et al. A comprehensive systematic review and meta-analysis of the association between the neutrophil-to-lymphocyte ratio and adverse outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. Journal of clinical medicine. 2022 Jun 11;11(12):3365.
  9. Ardestani ME, Naeini NA. Evaluation of the prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbation of chronic obstructive pulmonary disease. Journal of Research in Medical Sciences. 2022 Jan 1;27(1):50.
  10. Hedhliabir A, Slim A, Rouhou SC, Khaled SB, Taboubi A, Ouahchi Y, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease.
  11. Zuo H, Xie X, Peng J, Wang L, Zhu R. Predictive value of novel inflammation‐based biomarkers for pulmonary hypertension in the acute exacerbation of chronic obstructive pulmonary disease. Analytical Cellular Pathology. 2019;2019(1):5189165.
  12. Teng F, Ye H, Xue T. Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease. PloS one. 2018 Sep 28;13(9):e0204377.
  13. Tamaki S, Nagai Y, Shutta R, Masuda D, Yamashita S, Seo M, et al. Combination of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study. Journal of the American Heart Association. 2023 Jan 3;12(1):e026326.
  14. Wang R, Wu J, Ye H, Zhang X, Wang L. Application value of systemic inflammatory indexes in the clinical evaluation of patients with heart failure with preserved ejection fraction (HFpEF). Medicina. 2022 Oct 17;58(10):1473.
  15. Özkaramanlı Gür D, Alpsoy Ş, Baykız D, Akyüz A. Relationship between plasma osmolality and neutrophil/lymphocyte ratio in heart failure with reduced ejection fraction. Annals of Medical Research. 2022.
  16. Duan Y, Peng Z, Zhong S, Huang H, He Z. Association between subclinical left ventricular ejection fraction and platelet-to-lymphocyte ratio in patients with peritoneal dialysis. Frontiers in Medicine. 2022 Dec 1;9:961453.
Journal of Cardio-Thoracic Medicine
Volume 12, Issue 3
September 2024
Pages 1402-1409

Files

Share

How to cite

Statistics